Aldeyra Therapeutics Inc (ALDX)
3.95
+0.04
(+1.02%)
USD |
NASDAQ |
Apr 24, 16:00
3.95
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Market Cap: 232.64M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 23, 2024 | 230.28M |
April 22, 2024 | 231.46M |
April 19, 2024 | 227.34M |
April 18, 2024 | 234.41M |
April 17, 2024 | 233.82M |
April 16, 2024 | 227.93M |
April 15, 2024 | 245.01M |
April 12, 2024 | 250.31M |
April 11, 2024 | 259.14M |
April 10, 2024 | 250.31M |
April 09, 2024 | 260.91M |
April 08, 2024 | 257.96M |
April 05, 2024 | 277.99M |
April 04, 2024 | 275.93M |
April 03, 2024 | 244.42M |
April 02, 2024 | 209.08M |
April 01, 2024 | 192.59M |
March 28, 2024 | 192.59M |
March 27, 2024 | 181.40M |
March 26, 2024 | 171.98M |
March 25, 2024 | 169.62M |
March 22, 2024 | 170.80M |
March 21, 2024 | 171.39M |
March 20, 2024 | 171.98M |
March 19, 2024 | 167.85M |
Date | Value |
---|---|
March 18, 2024 | 163.73M |
March 15, 2024 | 164.32M |
March 14, 2024 | 163.14M |
March 13, 2024 | 170.80M |
March 12, 2024 | 176.98M |
March 11, 2024 | 191.41M |
March 08, 2024 | 213.20M |
March 07, 2024 | 226.75M |
March 06, 2024 | 231.46M |
March 05, 2024 | 231.46M |
March 04, 2024 | 240.93M |
March 01, 2024 | 249.81M |
February 29, 2024 | 214.29M |
February 28, 2024 | 218.43M |
February 27, 2024 | 223.17M |
February 26, 2024 | 216.66M |
February 23, 2024 | 206.59M |
February 22, 2024 | 209.55M |
February 21, 2024 | 198.31M |
February 20, 2024 | 203.63M |
February 16, 2024 | 212.51M |
February 15, 2024 | 213.11M |
February 14, 2024 | 201.27M |
February 13, 2024 | 188.24M |
February 12, 2024 | 200.67M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
48.05M
Minimum
Mar 16 2020
747.48M
Maximum
Jun 08 2021
316.80M
Average
268.89M
Median
Aug 25 2020
Market Cap Benchmarks
AbbVie Inc | 296.57B |
United Therapeutics Corp | 11.16B |
Heron Therapeutics Inc | 399.87M |
Esperion Therapeutics Inc | 391.39M |
FibroGen Inc | 96.84M |
Market Cap Related Metrics
Price to Book Value | 1.942 |
Price | 3.95 |
Earnings Yield | -16.20% |